SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] [amend]
SEC Accession No. 0001144204-12-025223
Filing Date
2012-05-01
Accepted
2012-05-01 14:02:12
Documents
8
Period of Report
2011-12-31
Filing Date Changed
2012-05-01

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 20-F v308264_20fa.htm 20-F/A 33651
8 GRAPHIC logo.jpg GRAPHIC 56491
  Complete submission text file 0001144204-12-025223.txt   2710223

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT rosg-20111231.xml EX-101.INS 488839
3 XBRL TAXONOMY EXTENSION SCHEMA rosg-20111231.xsd EX-101.SCH 23715
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rosg-20111231_cal.xml EX-101.CAL 34676
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rosg-20111231_def.xml EX-101.DEF 84618
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE rosg-20111231_lab.xml EX-101.LAB 199675
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rosg-20111231_pre.xml EX-101.PRE 112183
Mailing Address 10 PLAUT STREET, SCIENCE PARK POB 4059 REHOVOT L3 76706
Business Address 10 PLAUT STREET, SCIENCE PARK POB 4059 REHOVOT L3 76706 972-73-222-0700
Rosetta Genomics Ltd. (Filer) CIK: 0001362959 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-33042 | Film No.: 12799404
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1